Mylan N.V. Registration Rights Agreement $1,000,000,000 2.500% Senior Notes Due 2019 $2,250,000,000 3.150% Senior Notes Due 2021 $2,250,000,000 3.950% Senior Notes Due 2026 $1,000,000,000 5.250% Senior Notes Due 2046Registration Rights Agreement • June 15th, 2016 • Mylan N.V. • Pharmaceutical preparations • New York
This Registration Rights Agreement dated June 9, 2016 (this “Agreement”) is entered into by and among Mylan N.V., a public limited liability company (naamloze vennootschap) incorporated and existing under the laws of the Netherlands (the “Company”), Mylan Inc., a Pennsylvania corporation (the “Initial Guarantor”), and Deutsche Bank Securities Inc., Goldman, Sachs & Co. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representatives (the “Representatives”) of the several purchasers named in Schedules I(a), I(b), I(c) and I(d) to the Purchase Agreement (as defined below) (the “Initial Purchasers”).
